In focus
Latest feed
An Oncologist's Crucial Warning: Don't Ignore These Lump Red Flags
FDA Approves AstraZeneca’s New Breast‑Cancer Therapy Amid Access Hurdles
When a Breakthrough Pancreatic Cancer Drug Hits the Market, Insurance Still Plays Catch‑up
Tyra Biosciences Stock Jumps as Crucial Bladder Cancer Drug Data Looms
Latest headlines
